Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2012 | Clinical significance of thyroid transcription factor-1 in advanced lung adenocarcinoma under epidermal growth factor receptor tyrosine kinase inhibitor treatment | KUEI-PIN CHUNG ; Huang Y.-T.; YIH-LEONG CHANG ; CHONG-JEN YU ; CHIH-HSIN YANG ; YEUN-CHUNG CHANG ; JIN-YUAN SHIH ; PAN-CHYR YANG | Chest | 44 | 42 | |
2014 | Clinicopathologic characteristics and prognostic significance of EGFR and p53 mutations in surgically resected lung adenocarcinomas ≤2 cm in maximal dimension | MONG-WEI LIN ; CHEN-TU WU ; JIN-YUAN SHIH ; YIH-LEONG CHANG ; PAN-CHYR YANG | Journal of Surgical Oncology | 32 | 29 | |
2021 | Clinicopathologic Features and Response to Therapy of NRG1 Fusion–Driven Lung Cancers: The eNRGy1 Global Multicenter Registry | Drilon A.; Duruisseaux M.; Han J.-Y.; Ito M.; Falcon C.; Yang S.-R.; Murciano-Goroff Y.R.; Chen H.; Okada M.; Molina M.A.; Wislez M.; Brun P.; Dupont C.; Branden E.; Rossi G.; Schrock A.; Ali S.; Gounant V.; Magne F.; Blum T.G.; Schram A.M.; Monnet I.; JIN-YUAN SHIH ; Sabari J.; Pérol M.; Zhu V.W.; Nagasaka M.; Doebele R.; Camidge D.R.; Arcila M.; Ou S.-H.I.; Moro-Sibilot D.; Rosell R.; Muscarella L.A.; Liu S.V.; Cadranel J. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 29 | 20 | |
2021 | Clinicopathological features and survival outcomes of primary pulmonary invasive mucinous adenocarcinoma | Gow C.-H.; MIN-SHU HSIEH ; Liu Y.-N.; Lee Y.-H.; JIN-YUAN SHIH | Cancers | 10 | 8 | |
2011 | Clustered genomic alterations in chromosome 7p dictate outcomes and targeted treatment responses of lung adenocarcinoma with EGFR-activating mutations | Yuan S.; SUNG-LIANG YU ; Chen H.-Y.; Hsu Y.-C.; KANG-YI SU ; HUEI-WEN CHEN ; Chen C.-Y.; CHONG-JEN YU ; JIN-YUAN SHIH ; YIH-LEONG CHANG ; Cheng C.-L.; Hsu C.-P.; Hsia J.-Y.; Lin C.-Y.; Wu G.; Liu C.-H.; Wang C.-D.; Yang K.-C.; Chen Y.-W.; Lai Y.-L.; Hsu C.-C.; Lin T.-C.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Chen J.J.W.; Chang G.-C.; Li K.-C.; PAN-CHYR YANG | Journal of Clinical Oncology | 28 | 26 | |
2016 | Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis | Chen L.-Y.; Molina-Vila M.A ; SHENG-YUAN RUAN ; KANG-YI SU ; WEI-YU LIAO ; KAI-LUN YU ; CHAO-CHI HO ; JIN-YUAN SHIH ; CHONG-JEN YU ; CHIH-HSIN YANG ; Rosell R.; PAN-CHYR YANG | Lung Cancer | 57 | 52 | |
2017 | Coexistence of the BRAF Mutation and EGFR Exon 20 Insertion in a Patient with Lung Adenocarcinoma | LIH-CHYUN CHANG ; KUAN-YU CHEN ; JIN-YUAN SHIH ; CHONG-JEN YU ; MIN-SHU HSIEH | Journal of Thoracic Oncology | 1 | 0 | |
2011 | Coinfection with Mycobacterium tuberculosis and pandemic H1N1 influenza A virus in a patient with lung cancer | Tan C.-K.; Kao C.-L.; JIN-YUAN SHIH ; LI-NA LEE ; CHIEN-CHING HUNG ; Lai C.-C.; YU-TSUNG HUANG ; PO-REN HSUEH | Journal of Microbiology, Immunology and Infection | 10 | 9 | |
2001 | Collapsin response mediator protein-1 and the invasion and metastasis of cancer cells | JIN-YUAN SHIH ; PAN-CHYR YANG ; Hong T.-M.; ANG YUAN ; Chen J.J.W.; CHONG-JEN YU ; YIH-LEONG CHANG ; Lee Y.-C.; Peck K.; Wu C.-W.; Yang P.-C. | Journal of the National Cancer Institute | 135 | 126 | |
2003 | Collapsin response mediator protein-1: A novel invasion-suppressor gene | JIN-YUAN SHIH ; Lee Y.-C.G.; Yang S.-C.; Hong T.-M.; Huang C.-Y.F.; PAN-CHYR YANG | Clinical and Experimental Metastasis | 52 | 50 | |
2018 | Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum | WEI-YU LIAO ; CHAO-CHI HO ; TZU-HSIU TSAI ; KUAN-YU CHEN ; JIN-YUAN SHIH ; CHONG-JEN YU | Lung Cancer | 14 | 11 | |
2017 | Comparable clinical outcomes in patients with HER2-mutant and EGFR-mutant lung adenocarcinomas | Gow C.-H.; Chang H.-T.; Lim C.-K.; Liu C.-Y.; JIN-SHING CHEN ; JIN-YUAN SHIH | Genes Chromosomes and Cancer | 15 | 15 | |
2009 | Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer | Gow C.-H.; YIH-LEONG CHANG ; Hsu Y.-C.; Tsai M.-F.; CHEN-TU WU ; CHONG-JEN YU ; CHIH-HSIN YANG ; Lee Y.-C.; PAN-CHYR YANG ; JIN-YUAN SHIH | Annals of Oncology | 195 | 172 | |
2011 | Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations | Wu J.-Y.; SHANG-GIN WU ; CHIH-HSIN YANG ; YIH-LEONG CHANG ; YEUN-CHUNG CHANG ; Hsu Y.-C.; JIN-YUAN SHIH ; PAN-CHYR YANG | Lung Cancer | 69 | 61 | |
2011 | Comparison of p53 and epidermal growth factor receptor gene status between primary tumors and lymph node metastases in non-small cell lung cancers | YIH-LEONG CHANG ; CHEN-TU WU ; JIN-YUAN SHIH ; Lee Y.-C. | Annals of Surgical Oncology | 44 | 38 | |
2020 | Complex EGFR mutations with secondary T790M mutation confer shorter osimertinib progression-free survival and overall survival in advanced non-small cell lung cancer | YEN-TING LIN ; TZU-HSIU TSAI ; SHANG-GIN WU ; Liu Y.-N.; CHONG-JEN YU ; JIN-YUAN SHIH | Lung Cancer | 17 | 17 | |
2017 | A comprehensive analysis of clinical outcomes in lung cancer patients harboring a MET exon 14 skipping mutation compared to other driver mutations in an East Asian population | Gow C.-H.; MIN-SHU HSIEH ; SHANG-GIN WU ; JIN-YUAN SHIH | Lung Cancer | 46 | 38 | |
2004 | Connective tissue growth factor and its role in lung adenocarcinoma invasion and metastasis | Chang C.-C.; JIN-YUAN SHIH ; YUNG-MING JENG ; Su J.-L.; Lin B.-Z.; Chen S.-T.; Chau Y.-P.; PAN-CHYR YANG ; Kuo M.-L. | Journal of the National Cancer Institute | 164 | 153 | |
2019 | Consecutive emergence of typical acquired resistance to EGFR tyrosine kinase inhibitors in a patient with metastatic pulmonary squamous cell carcinoma | Yang C.-Y.; MIN-SHU HSIEH ; WEI-YU LIAO ; JIN-YUAN SHIH ; CHONG-JEN YU | Journal of Oncology Practice | 0 | 0 | |
2010 | Correlation of F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value and EGFR mutations in advanced lung adenocarcinoma | CHUN-TA HUANG ; RUOH-FANG YEN ; MEI-FANG CHENG ; Hsu Y.-C.; Wei P.-F.; Tsai Y.-J.; Tsai M.-F.; JIN-YUAN SHIH ; CHIH-HSIN YANG ; PAN-CHYR YANG | Medical Oncology | 60 | 54 |